Through this initiative, the Centre for Trauma will create curriculums and facilitate trauma-related courses for healthcare professionals at both urban and grassroot levels
The Pune centre expands its presence beyond Bangalore and Hyderabad
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
Subscribe To Our Newsletter & Stay Updated
